About this trial

cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment

Eligibility criteria

Qualifiers

pulmonary arterial hypertension;( WHO1)

chronic thromboembolic pulmonary hypertension;

pulmonary arterial hypertension due to other cause;

Disqualifiers

massive hemoptysis;

unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders;

recent recurrent syncope;

pulmonary hypertension due to hypoxia;

Trial design

Treatments tested in this trial

  • balloon pulmonary angioplasty

Treatment groups

4,000 Participants
are divided into 1 treatment group

Locations

1
center of pulmonary vascular disease, Fuwai hospital100037, Beijing China

Sponsors and collaborators

Chinese Pulmonary Vascular Disease Research Group

Lead sponsor